The revised guidelines also will lead to more than $20 million in extra health care costs, the research shows.

HBV infection at birth or during early infancy can lead to lifelong health problems such as chronic liver disease and liver ...

Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. The Trump ...

The World Health Organization (WHO) released a new report on hepatitis today, marking the World Hepatitis Summit. Since 2015, ...

Amid policy shifts and a rise in misinformation fueling vaccine hesitancy, fewer infants in the U.S. are receiving the ...

Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...

The FDA has accepted for Priority Review the New Drug Application for bepirovirsen for the treatment of adults with chronic hepatitis B.

In 1990 I was a pediatric infectious disease physician at the National Naval Medical Center in Bethesda, Maryland. Our oncologist examined a patient who had an abdominal mass which turned out to be a ...

Countries are making measurable progress in combatting viral hepatitis, but the disease remains a major global health ...

New research warns that missing the hepatitis B vaccine at birth sharply reduces the likelihood of infants completing the full series, raising future infection risks. The findings come as the CDC’s ...

The Trump administration’s recommendation against universal hepatitis B vaccination for babies on the day they’re born could ...

New studies warn delaying the hepatitis B birth dose could leave more babies vulnerable to infection and long-term illness.